Philips acquires PathXL, ramps up digital pathology portfolio

Philips acquires PathXL, ramps up digital pathology portfolio

June 22, 2016
European News Rad Oncology Population Health

Still, there is work to be done getting digital pathology fully approved by the FDA as a reliable method of interpreting samples. Massachusetts General Hospital will be a testing site for a precision study, which will utilize Philips’ IntelliSite Solution for digital pathology disease detection, to provide evidence of consistency.

For the study, researchers will pit digital pathology and traditional slides "side by side, and have one pathologist read slides from all five and make sure he/she makes the same calls. They do a washout where they don’t do any reads for three to four weeks, so they forget the images, and then do the study again,” Granzow, told HCB News in March.

Back to HCB News


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

You Must Be Logged In To Post A Comment